← All companies
MCTA
Charming Medical Limited
$29.36
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$474M
Revenue (TTM)
$4.81M
Net income (TTM)
-$22.6K
EPS (TTM)
$0.00
P/E ratio
—
Dividend yield
—
Free cash flow
-$1.56M
Cash
$4.70M
Total assets
$9.87M
Gross margin
—
52-week range
$4.30 – $31.70
Recent SEC filings
36 most recentAnnual, quarterly & current reports
20-F
ANNUAL REPORT
Jul 30, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Jul 21, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
May 6, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Apr 2, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Mar 31, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Mar 27, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Jan 6, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Nov 28, 2025
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Nov 13, 2025
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Oct 28, 2025
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Oct 22, 2025
Other filings
SCHEDULE 13D
Mar 27, 2026
3
Mar 27, 2026
3
Mar 27, 2026
3
Mar 27, 2026
424B4
PROSPECTUS
Oct 21, 2025
CERT
Oct 20, 2025
8-A12B
FOR REGISTRATION OF CERTAIN CLASSES
Oct 20, 2025
EFFECT
Sep 30, 2025
CORRESP
Sep 29, 2025
CORRESP
Sep 29, 2025
F-1/A
AMENDMENT NO. 3 TO FORM F-1
Sep 10, 2025
FWP
FREE WRITING PROSPECTUS
Aug 7, 2025
F-1/A
REGISTRATION STATEMENT
Jul 30, 2025
FWP
FREE WRITING PROSPECTUS
Jun 3, 2025
CORRESP
May 27, 2025
F-1/A
REGISTRATION STATEMENT
May 27, 2025
UPLOAD
May 19, 2025
F-1
REGISTRATION STATEMENT
May 14, 2025
DRSLTR
Apr 28, 2025
DRS/A
Apr 28, 2025
UPLOAD
Mar 25, 2025
DRS/A
Mar 10, 2025
DRSLTR
Mar 7, 2025
UPLOAD
Dec 18, 2024
DRS
Nov 21, 2024